This inventor holds 20 USPTO granted patents and 17 published patent applications, plus 4 CIPO patents and 5 EPO patents, primarily in Pharmaceutical Formulations. Top assignees: Tremeau Pharmaceuticals, Inc., 3M Innovative Properties Company, Millennium Pharmaceuticals Limited. Active years: 2001-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Oakdale, MN (US) (2001 - 2011)
- Saint Paul, MN (US) (2016)
- Cambridge, MA (US) (2021)
- Andover, MA (US) (2014 - 2024)
Company Filing History:
6 out of 8 
5 out of 22,412 
5 out of 855 
Years Active: 2001-2024
Areas of Expertise:
Title: Raymond D Skwierczynski: Innovator in Pharmaceutical Patents
Introduction
Raymond D Skwierczynski is a prominent inventor located in Andover, MA, known for his significant contributions to the field of pharmaceuticals. With a total of 20 patents to his name, Skwierczynski has made remarkable advancements in the realm of drug formulation, focusing particularly on rofecoxib.
Latest Patents
Among his latest contributions, Skwierczynski has developed purified forms of rofecoxib, also referred to as TRM-201 or RXB-201. The subject matter of this patent outlines the methods of manufacture and use of this compound. In several aspects, the highly pure or substantially pure rofecoxib showcased in these patents exhibits a favorable purity profile, serving as an active ingredient in pharmaceutical compositions intended to treat or prevent various conditions, including pain related to bleeding disorders.
Career Highlights
Skwierczynski has garnered experience from working with notable companies in the industry, including Tremeau Pharmaceuticals, Inc. and 3M Innovative Properties Company. His work in these organizations has contributed to his expertise in the development of innovative pharmaceutical solutions.
Collaborations
Throughout his career, Skwierczynski has collaborated with esteemed colleagues, including Eric L Elliott and Abu J Ferdous. These collaborations reflect a synergy of knowledge and innovation aimed at advancing pharmaceutical research and development.
Conclusion
Raymond D Skwierczynski stands out as a key innovator in the pharmaceutical field, with his patents paving the way for improved treatment options. His dedication to creating high-purity compounds like rofecoxib demonstrates not only his commitment to healthcare innovation but also highlights his role as a significant contributor in the realm of patents and inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile